[ { "biomarker_canonical_id": "AN6586", "biomarker_id": "AN6586-1", "biomarker": "increased LAMTOR1 level", "assessed_biomarker_entity_id": "Q6IAA8-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Ragulator complex protein LAMTOR1", "specimen": "urine (0001088)", "best_biomarker_role": "diagnostic", "condition": "prostate cancer (DOID:10283)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6586-1", "record_type": "biomarker", "filter_code": "01.1000000" }, { "biomarker_canonical_id": "AN6587", "biomarker_id": "AN6587-1", "biomarker": "increased TM256 level", "assessed_biomarker_entity_id": "Q8N2U0-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Transmembrane protein 256", "specimen": "urine (0001088)", "best_biomarker_role": "diagnostic", "condition": "prostate cancer (DOID:10283)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6587-1", "record_type": "biomarker", "filter_code": "01.1000000" }, { "biomarker_canonical_id": "AN6588", "biomarker_id": "AN6588-1", "biomarker": "increased FKBP4 level", "assessed_biomarker_entity_id": "Q02790-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Peptidyl-prolyl cis-trans isomerase FKBP4", "specimen": "prostate gland (0002367)", "best_biomarker_role": "diagnostic", "condition": "prostate cancer (DOID:10283)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6588-1", "record_type": "biomarker", "filter_code": "01.1000000" }, { "biomarker_canonical_id": "AN6589", "biomarker_id": "AN6589-1", "biomarker": "decreased FLNA level", "assessed_biomarker_entity_id": "P21333-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Filamin-A", "specimen": "prostate gland (0002367)", "best_biomarker_role": "diagnostic", "condition": "prostate cancer (DOID:10283)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6589-1", "record_type": "biomarker", "filter_code": "01.1000000" }, { "biomarker_canonical_id": "AN6590", "biomarker_id": "AN6590-1", "biomarker": "increased MYO5A level", "assessed_biomarker_entity_id": "Q9Y4I1-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Unconventional myosin-Va", "specimen": "blood (0000178)", "best_biomarker_role": "monitoring", "condition": "lung cancer (DOID:1324)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6590-1", "record_type": "biomarker", "filter_code": "01.0100000" }, { "biomarker_canonical_id": "AN6591", "biomarker_id": "AN6591-1", "biomarker": "increased WASF1 level", "assessed_biomarker_entity_id": "Q92558-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Actin-binding protein WASF1", "specimen": "blood (0000178)", "best_biomarker_role": "monitoring", "condition": "lung cancer (DOID:1324)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6591-1", "record_type": "biomarker", "filter_code": "01.0100000" }, { "biomarker_canonical_id": "AN6592", "biomarker_id": "AN6592-1", "biomarker": "increased PDHB level", "assessed_biomarker_entity_id": "P11177-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Pyruvate dehydrogenase E1 component subunit beta, mitochondrial", "specimen": "blood (0000178)", "best_biomarker_role": "predictive", "condition": "lung cancer (DOID:1324)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6592-1", "record_type": "biomarker", "filter_code": "01.0010000" }, { "biomarker_canonical_id": "AN6595", "biomarker_id": "AN6595-1", "biomarker": "increased CXCR4 level", "assessed_biomarker_entity_id": "P61073-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "C-X-C chemokine receptor type 4", "specimen": "skin epidermis (0001003)", "best_biomarker_role": "prognostic", "condition": "skin cancer (DOID:4159)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6595-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6595", "biomarker_id": "AN6595-2", "biomarker": "increased CXCR4 level", "assessed_biomarker_entity_id": "P61073-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "C-X-C chemokine receptor type 4", "specimen": "esophagus (0001043)", "best_biomarker_role": "prognostic", "condition": "esophageal cancer (DOID:5041)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6595-2", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6596", "biomarker_id": "AN6596-1", "biomarker": "increased CTSB level", "assessed_biomarker_entity_id": "P07858-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Cathepsin B", "specimen": "blood (0000178)", "best_biomarker_role": "prognostic", "condition": "skin cancer (DOID:4159)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6596-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6601", "biomarker_id": "AN6601-1", "biomarker": "decreased CLDN4 level", "assessed_biomarker_entity_id": "O14493-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Claudin-4", "specimen": "ovary (0000992)", "best_biomarker_role": "prognostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6601-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6602", "biomarker_id": "AN6602-1", "biomarker": "decreased MLH1 level", "assessed_biomarker_entity_id": "P40692-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "DNA mismatch repair protein Mlh1", "specimen": "ovary (0000992)", "best_biomarker_role": "prognostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6602-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6609", "biomarker_id": "AN6609-1", "biomarker": "increased EZH2 level", "assessed_biomarker_entity_id": "Q15910-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Histone-lysine N-methyltransferase EZH2", "specimen": "prostate gland (0002367)", "best_biomarker_role": "prognostic", "condition": "prostate cancer (DOID:10283)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6609-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6610", "biomarker_id": "AN6610-1", "biomarker": "increased FABP4 level", "assessed_biomarker_entity_id": "P15090-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Fatty acid-binding protein, adipocyte", "specimen": "blood (0000178)", "best_biomarker_role": "risk", "condition": "breast cancer (DOID:1612)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6610-1", "record_type": "biomarker", "filter_code": "01.0000100" }, { "biomarker_canonical_id": "AN6611", "biomarker_id": "AN6611-1", "biomarker": "increased ENG level", "assessed_biomarker_entity_id": "P17813-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Endoglin", "specimen": "urine (0001088)", "best_biomarker_role": "prognostic", "condition": "prostate cancer (DOID:10283)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6611-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6612", "biomarker_id": "AN6612-1", "biomarker": "increased AMACR level", "assessed_biomarker_entity_id": "Q9UHK6-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Alpha-methylacyl-CoA racemase", "specimen": "urine (0001088)", "best_biomarker_role": "risk", "condition": "prostate cancer (DOID:10283)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6612-1", "record_type": "biomarker", "filter_code": "01.0000100" }, { "biomarker_canonical_id": "AN6613", "biomarker_id": "AN6613-1", "biomarker": "increased IMPDH2 level", "assessed_biomarker_entity_id": "P12268-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Inosine-5'-monophosphate dehydrogenase 2", "specimen": "ovary (0000992)", "best_biomarker_role": "prognostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6613-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6622", "biomarker_id": "AN6622-1", "biomarker": "increased TNFRSF11B level", "assessed_biomarker_entity_id": "O00300-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Tumor necrosis factor receptor superfamily member 11B", "specimen": "blood (0000178)", "best_biomarker_role": "risk", "condition": "breast cancer (DOID:1612)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6622-1", "record_type": "biomarker", "filter_code": "01.0000100" }, { "biomarker_canonical_id": "AN6625", "biomarker_id": "AN6625-1", "biomarker": "increased PRDX-1 level", "assessed_biomarker_entity_id": "Q06830-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Peroxiredoxin-1", "specimen": "ovary (0000992)", "best_biomarker_role": "prognostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6625-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6626", "biomarker_id": "AN6626-1", "biomarker": "increased HSPB1 level", "assessed_biomarker_entity_id": "P04792-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Heat shock protein beta-1", "specimen": "blood (0000178)", "best_biomarker_role": "prognostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6626-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6627", "biomarker_id": "AN6627-1", "biomarker": "increased REG4 level", "assessed_biomarker_entity_id": "Q9BYZ8-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Regenerating islet-derived protein 4", "specimen": "blood (0000178)", "best_biomarker_role": "diagnostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6627-1", "record_type": "biomarker", "filter_code": "01.1000000" }, { "biomarker_canonical_id": "AN6627", "biomarker_id": "AN6627-2", "biomarker": "increased REG4 level", "assessed_biomarker_entity_id": "Q9BYZ8-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Regenerating islet-derived protein 4", "specimen": "stomach (0000945)", "best_biomarker_role": "diagnostic", "condition": "stomach cancer (DOID:10534)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6627-2", "record_type": "biomarker", "filter_code": "01.1000000" }, { "biomarker_canonical_id": "AN6630", "biomarker_id": "AN6630-1", "biomarker": "increased SREBP1 level", "assessed_biomarker_entity_id": "P36956-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Sterol regulatory element-binding protein 1", "specimen": "thyroid gland (0002046)", "best_biomarker_role": "diagnostic", "condition": "thyroid cancer (DOID:1781)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6630-1", "record_type": "biomarker", "filter_code": "01.1000000" }, { "biomarker_canonical_id": "AN6631", "biomarker_id": "AN6631-1", "biomarker": "decreased ANXA3 level", "assessed_biomarker_entity_id": "P12429-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Annexin A3", "specimen": "prostate gland (0002367)", "best_biomarker_role": "prognostic", "condition": "prostate cancer (DOID:10283)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6631-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6633", "biomarker_id": "AN6633-1", "biomarker": "increased HOXC6 level", "assessed_biomarker_entity_id": "P09630-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Homeobox protein Hox-C6", "specimen": "prostate gland (0002367)", "best_biomarker_role": "prognostic", "condition": "prostate cancer (DOID:10283)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6633-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6635", "biomarker_id": "AN6635-1", "biomarker": "increased AGR2 level", "assessed_biomarker_entity_id": "O95994-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Anterior gradient protein 2 homolog", "specimen": "ovary (0000992)", "best_biomarker_role": "diagnostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6635-1", "record_type": "biomarker", "filter_code": "01.1000000" }, { "biomarker_canonical_id": "AN6635", "biomarker_id": "AN6635-2", "biomarker": "increased AGR2 level", "assessed_biomarker_entity_id": "O95994-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Anterior gradient protein 2 homolog", "specimen": "stomach (0000945)", "best_biomarker_role": "prognostic", "condition": "stomach cancer (DOID:10534)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6635-2", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6636", "biomarker_id": "AN6636-1", "biomarker": "increased CTSD level", "assessed_biomarker_entity_id": "P07339-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Cathepsin D", "specimen": "stomach (0000945)", "best_biomarker_role": "prognostic", "condition": "stomach cancer (DOID:10534)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6636-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6637", "biomarker_id": "AN6637-1", "biomarker": "increased PLG level", "assessed_biomarker_entity_id": "P00747-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Plasminogen", "specimen": "ovary (0000992)", "best_biomarker_role": "prognostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6637-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6639", "biomarker_id": "AN6639-1", "biomarker": "increased HMGA1 level", "assessed_biomarker_entity_id": "P17096-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "High mobility group protein HMG-I/HMG-Y", "specimen": "urine (0001088)", "best_biomarker_role": "diagnostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6639-1", "record_type": "biomarker", "filter_code": "01.1000000" }, { "biomarker_canonical_id": "AN6641", "biomarker_id": "AN6641-1", "biomarker": "decreased BTG1 level", "assessed_biomarker_entity_id": "P62324-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Protein BTG1", "specimen": "", "best_biomarker_role": "prognostic", "condition": "thyroid cancer (DOID:1781)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6641-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6642", "biomarker_id": "AN6642-1", "biomarker": "increased CAP2 level", "assessed_biomarker_entity_id": "P40123-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Adenylyl cyclase-associated protein 2", "specimen": "ovary (0000992)", "best_biomarker_role": "prognostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6642-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6643", "biomarker_id": "AN6643-1", "biomarker": "increased RNF126 level", "assessed_biomarker_entity_id": "Q9BV68-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "E3 ubiquitin-protein ligase RNF126", "specimen": "ovary (0000992)", "best_biomarker_role": "prognostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6643-1", "record_type": "biomarker", "filter_code": "01.0001000" }, { "biomarker_canonical_id": "AN6644", "biomarker_id": "AN6644-1", "biomarker": "increased KLK10 level", "assessed_biomarker_entity_id": "O43240-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Kallikrein-10", "specimen": "blood (0000178)", "best_biomarker_role": "prognostic", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "AN6644-1", "record_type": "biomarker", "filter_code": "01.0001000" } ]